✦ LIBER ✦

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Scribed by Cesar A. Perez; Hunho Song; Luis E. Raez; Mark Agulnik; Tatyana A. Grushko; Allison Dekker; Kerstin Stenson; Elizabeth A. Blair; Olufunmilayo I. Olopade; Tanguy Y. Seiwert; Everett E. Vokes; Ezra E.W. Cohen

Book ID: 119339241
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 328 KB
Volume: 48
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2012.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of the antiangiogenesis a

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Jennifer E. Tseng; Bonnie S. Glisson; Fadlo R. Khuri; Dong M. Shin; Jeffrey N. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

327 Phase II Study of Cetuximab and Lena

327 Phase II Study of Cetuximab and Lenalidomide in Recurrent/metastatic Squamous Cell Carcinoma of the Head and Neck

✍ Taylor, R.; Wong, S.; Chan, A.; Silipino, L.; Villaflor, V.; Vokes, E.; de Souza 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Erlotinib and bevacizumab in patients wi

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

Phase II study of pemetrexed in combinat

Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Vermorken, J.B.; Licitra, L.; Stöhlmacher-Williams, J.; Dietz, A.; Lopez-Picazo, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 281 KB

A randomized phase II study of docetaxel

A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

✍ Limaye, Sewanti; Riley, Sarah; Zhao, Sihai; O’Neill, Anne; Posner, Marshall; Adk 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 375 KB